InsiderClue
Insiders · Profile

Lingamneni Anila

EVP, Chief Technology Officer at HAEMONETICS. Filing since 16 Apr 2021. CIK 0001808414

Company
Date
Role
Action
Shares
Amount
Of holding
HAE HAEMONETICS CORP
12 Jul 2024
EVP, Chief Technology Officer
Sold on a plan
79
$7.11K
0.4%
HAE HAEMONETICS CORP
11 Jul 2024
EVP, Chief Technology Officer
Sold on a plan
2,136
$192.24K
9.1%
HAE HAEMONETICS CORP
6 May 2024
EVP, Chief Technology Officer
Sold on a plan
2,305
$218.98K
15.8%
HAE HAEMONETICS CORP
11 Sep 2023
EVP, Chief Technology Officer
Sold on a plan
2,305
$207.45K
13.7%
HAE HAEMONETICS CORP
30 May 2023
EVP, Chief Technology Officer
Sold at will
2,304
$191.99K
12.1%
HAE HAEMONETICS CORP
19 May 2022
EVP, Chief Technology Officer
Sold, plan not stated
1,384
$81.79K
7.4%
HAE HAEMONETICS CORP
18 Apr 2022
EVP, Chief Technology Officer
Sold, plan not stated
189
$10.69K
1.3%
HAE HAEMONETICS CORP
19 May 2021
EVP, Chief Technology Officer
Sold, plan not stated
92
$5.08K
0.6%
HAE HAEMONETICS CORP
16 Apr 2021
EVP, Chief Technology Officer
Sold, plan not stated
170
$20.30K
4.7%
9 decisions on file.